[go: up one dir, main page]

GT199800149A - Formulaciones parasiticidas. - Google Patents

Formulaciones parasiticidas.

Info

Publication number
GT199800149A
GT199800149A GT199800149A GT199800149A GT199800149A GT 199800149 A GT199800149 A GT 199800149A GT 199800149 A GT199800149 A GT 199800149A GT 199800149 A GT199800149 A GT 199800149A GT 199800149 A GT199800149 A GT 199800149A
Authority
GT
Guatemala
Prior art keywords
parasiticide formulations
parasiticide
formulations
milbemicine
parasitical
Prior art date
Application number
GT199800149A
Other languages
English (en)
Inventor
Hiep Huatan
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9720228.7A external-priority patent/GB9720228D0/en
Priority claimed from GBGB9810143.9A external-priority patent/GB9810143D0/en
Application filed filed Critical
Publication of GT199800149A publication Critical patent/GT199800149A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Neurosurgery (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

LA INVENCION APORTA UN IMPLANTE SOLIDO QUE COMPRENDE AL MENOS UN COMPUESTO PARASITICIDA QUE PUEDE SER UNA AVERMECTINA O UNA MILBEMICINA QUE TIENE UNA BAJA SOLUBILIDAD ACUOSA Y EXCIPIENTES DE COMPRENSION ENTRE LOS QUE SE INCLUYE UN AGENTE DE RELLENO. LOS IMPLANTES DE ACUERDO CON LA INVENCION SON COMODOS DE ADMINISTRAR Y PROPORCIONAN UNA PROTECCION PROLONGADA FRENTE A PARASITOS.
GT199800149A 1997-09-23 1998-09-22 Formulaciones parasiticidas. GT199800149A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GBGB9720228.7A GB9720228D0 (en) 1997-09-23 1997-09-23 Parasiticidal formulations
GBGB9810143.9A GB9810143D0 (en) 1998-05-12 1998-05-12 Parasiticidal formulations

Publications (1)

Publication Number Publication Date
GT199800149A true GT199800149A (es) 2000-03-15

Family

ID=26312302

Family Applications (1)

Application Number Title Priority Date Filing Date
GT199800149A GT199800149A (es) 1997-09-23 1998-09-22 Formulaciones parasiticidas.

Country Status (13)

Country Link
EP (1) EP1014970A1 (es)
JP (1) JP2001517622A (es)
AP (1) AP9801350A0 (es)
AR (1) AR013509A1 (es)
AU (1) AU9742298A (es)
BR (1) BR9812385A (es)
CA (1) CA2304283A1 (es)
GT (1) GT199800149A (es)
MA (1) MA24655A1 (es)
PA (1) PA8459501A1 (es)
PE (1) PE117199A1 (es)
TN (1) TNSN98175A1 (es)
WO (1) WO1999015166A1 (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AUPP279698A0 (en) * 1998-04-03 1998-04-30 Sunscape Developments Limited Sustained release formulation
US6645192B2 (en) 1998-09-30 2003-11-11 Ivy Animal Health, Inc. Pellet implant system for immediate and delayed release of antiparasitic drug
WO2001037811A1 (en) * 1999-11-22 2001-05-31 Akzo Nobel N.V. Composition allowing predefined and controlled release of active ingredient, preparation thereof and use
US6953586B1 (en) 2000-06-08 2005-10-11 Ivy Animal Health, Inc. Growth promoting pharmaceutical implant
DE10032878A1 (de) * 2000-07-06 2002-01-17 Bayer Ag Anthelmintika zur Verhinderung von parasitären Infektionen bei Mensch und Tier
AUPR602401A0 (en) * 2001-06-29 2001-07-26 Smart Drug Systems Inc Sustained release delivery system
AUPR602501A0 (en) * 2001-06-29 2001-07-26 Smart Drug Systems Inc Sustained release pharmaceutical composition
AUPR610501A0 (en) * 2001-07-04 2001-07-26 Smart Drug Systems Inc Treatment of parasitic disease
US7918863B2 (en) 2005-06-24 2011-04-05 Conceptus, Inc. Minimally invasive surgical stabilization devices and methods
WO2018226512A1 (en) * 2017-06-06 2018-12-13 Merck Sharp & Dohme Corp. Long-action implant for treatment of infectious diseases

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0240274A3 (en) * 1986-04-03 1990-03-14 Merck & Co. Inc. Avermectins as growth promotant agents
US4847243A (en) * 1987-10-08 1989-07-11 Merck & Co., Inc. Treatment for fescue toxicosis in grazing animals
NZ239370A (en) * 1990-08-22 1994-04-27 Merck & Co Inc Bioerodible implantable controlled release dosage form comprising a poly(ortho ester) or a polyacetal with an active agent incorporated into the chain backbone
US5411737A (en) * 1991-10-15 1995-05-02 Merck & Co., Inc. Slow release syneresing polymeric drug delivery device

Also Published As

Publication number Publication date
EP1014970A1 (en) 2000-07-05
JP2001517622A (ja) 2001-10-09
WO1999015166A1 (en) 1999-04-01
PE117199A1 (es) 1999-11-20
CA2304283A1 (en) 1999-04-01
PA8459501A1 (es) 2000-05-24
MA24655A1 (fr) 1999-04-01
TNSN98175A1 (fr) 2005-03-15
AR013509A1 (es) 2000-12-27
AU9742298A (en) 1999-04-12
AP9801350A0 (en) 2000-03-17
BR9812385A (pt) 2000-09-12

Similar Documents

Publication Publication Date Title
ES2123323T3 (es) Asociacion de un compuesto con actividad antimicrobiana (por ejemplo lipoaminoacido n,n-octanoilglicina) y de un monoalquileter de glicerol y su uso como agente antimicrobiano.
PA8575701A1 (es) Preparaciones acidas de insulina con estabilidad mejorada
CY1108532T1 (el) Ενωσεις και συνθεσεις για την παροχη δραστικων παραγοντων
BR0112054A (pt) Composição formadora de micelas, e métodos para a administração e a proteção de um agente terapêutico
ES2190075T3 (es) Formulaciones farmaceuticas solidas que contienen una mezcla fisica de sulfoalquil-eter-ciclodextrina y un agente terapeutico.
PA8484301A1 (es) Formulaciones farmaceuticas de liberacion controlada
GT199800037A (es) Combinaciones para diabetes de sulfonilurea - glitazona.
TR200100931T2 (tr) Yeni sürekli salınımlı oral formülasyonlar
ES2162319T3 (es) Uso del agente quelante clioquinol para la fabricacion de una composicion farmaceutica para el tratamiento de la enfermedad de alzheimer.
AR084885A2 (es) Implante para implantacion subcutanea en un animal
DE69921318D1 (de) Tensid für äusserlich anzuwendende hautpräparate und diese beinhaltende äusserlich anzuwendende hautpräparate
GT199800149A (es) Formulaciones parasiticidas.
CU23241B7 (es) 2-fenil-1-(4(2-aminoetoxi)-benzil)-indol en combinacion con estrogenos
AR032387A1 (es) Dentifrico con doble compuesto para la reduccion del mal aliento
CO4700420A1 (es) Formulacion transdermica
NO331082B1 (no) Formulering av kahalalid F, sett omfattende en slik formulering, samt rekonstituert losning derav og anvendelse av en fortynnet rekonstituert losning til fremstilling av et medikament for behandling av kreft
ES2167853T3 (es) N-aril 2-hidroxi alquilamidas.
AR025060A1 (es) Formulaciones farmaceuticas en capsulas de hidroxipropilmetilcelulosa
AR004077A1 (es) Una composicion particularmente cosmetica, y mas particularmente para la deformacion permanente de las fibras queratinicas.
AR022250A1 (es) Envase farmaceutico de uso para el tratamiento y prevencion de infecciones por el virus de la hepatitis b, procedimiento para el tratamiento de pacientes o pacientes susceptibles en padecer infecciones por el virus de la hepatitis b.
ITMI20031714A1 (it) Formazioni ad azione antitumorale.
CO4750591A1 (es) Procedimiento de lucha contra los insectos
ES2057759T3 (es) Composicion de iontoforesis para aumentar la concentracion de agentes activos en la piel.
ES2191426T3 (es) Composiciones estables que comprenden levosimendano y acido alginico.
ES2196171T3 (es) Agentes antitumorales de tioxantenona liofilizada.